Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-017715

Director sold 1,270 shares at $21.48 ($27,278)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Heyman Richard A. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-06-17 Sale : show line 1 in the form 10b5-1 −1,270 $21.48 $27,278 134,615 D
Open-market sales · 1,270 sh · avg $21.48 · $27,278
Loading xslF345X05/form4-06202024_110634.xml…